The recent global outbreak of COVID-19 has highlighted how Pandemics stress all aspects of healthcare and cause significant economic, social and political disruption, exposing gaps in our abilities to detect new or emerging pathogens, especially when no treatments exist. The need for millions of healthy patients to be vaccinated or infected patients to be treated has spurred renewed interest in vaccines as well as approaches to accelerate drug development timelines to deliver safe and efficacious treatments to market. Today there are over 50 treatments in various stages of development for COVID-19.

This presentation is an overview of the role Biacore SPR is playing in COVID-19 and highlight how modern platform technology are accelerating our ability to respond to emerging pandemics from understanding structure and function to the development of diagnostics and therapeutic interventions

Speaker

Dr. Paul Belcher, Global Product Strategy Manager, Biacore, Cytiva